4
Changes in Ownership
Ultragenyx Pharmaceutical Inc. Filed Acc 0001677455-26-000002
EVP and Chief Legal Officer sold 1,899 shares at $24.62 ($46,753)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Parschauer Karah Herdman EVP and Chief Legal Officer | 2026-06-15 | Sale 10b5-1 | −1,899 | $24.62 | $46,753 | 94,462 | D: show line 1 in the form |
| Open-market sales · 1,899 sh · avg $24.62 · $46,753 | |||||||
Loading xslF345X06/ownership.xml…